307 related articles for article (PubMed ID: 22413863)
41. Cyclopeptide Smac mimetics as antagonists of IAP proteins.
Sun H; Liu L; Lu J; Qiu S; Yang CY; Yi H; Wang S
Bioorg Med Chem Lett; 2010 May; 20(10):3043-6. PubMed ID: 20443226
[TBL] [Abstract][Full Text] [Related]
42. Novel promising IAP antagonist on the horizon for clinical translation.
Fulda S
J Med Chem; 2012 May; 55(9):4099-100. PubMed ID: 22515144
[No Abstract] [Full Text] [Related]
43.
Ohoka N; Okuhira K; Ito M; Nagai K; Shibata N; Hattori T; Ujikawa O; Shimokawa K; Sano O; Koyama R; Fujita H; Teratani M; Matsumoto H; Imaeda Y; Nara H; Cho N; Naito M
J Biol Chem; 2017 Mar; 292(11):4556-4570. PubMed ID: 28154167
[TBL] [Abstract][Full Text] [Related]
44. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.
Hahm ER; Singh SV
Cancer Lett; 2013 Jun; 334(1):101-8. PubMed ID: 22935676
[TBL] [Abstract][Full Text] [Related]
45. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.
Huang Y; Rich RL; Myszka DG; Wu H
J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414
[TBL] [Abstract][Full Text] [Related]
46. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
Nikolovska-Coleska Z; Xu L; Hu Z; Tomita Y; Li P; Roller PP; Wang R; Fang X; Guo R; Zhang M; Lippman ME; Yang D; Wang S
J Med Chem; 2004 May; 47(10):2430-40. PubMed ID: 15115387
[TBL] [Abstract][Full Text] [Related]
47. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.
Yang J; McEachern D; Li W; Davis MA; Li H; Morgan MA; Bai L; Sebolt JT; Sun H; Lawrence TS; Wang S; Sun Y
Mol Cancer Ther; 2011 Apr; 10(4):658-69. PubMed ID: 21282353
[TBL] [Abstract][Full Text] [Related]
48. Smac mimetic compounds potentiate interleukin-1beta-mediated cell death.
Cheung HH; Beug ST; St Jean M; Brewster A; Kelly NL; Wang S; Korneluk RG
J Biol Chem; 2010 Dec; 285(52):40612-23. PubMed ID: 20956527
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases.
Zhang B; Nikolovska-Coleska Z; Zhang Y; Bai L; Qiu S; Yang CY; Sun H; Wang S; Wu Y
J Med Chem; 2008 Dec; 51(23):7352-5. PubMed ID: 19012392
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
[TBL] [Abstract][Full Text] [Related]
51. Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.
Hong SW; Shin JS; Moon JH; Jung SA; Koh DI; Ryu Y; Park YS; Kim DY; Park SS; Hong JK; Kim EH; Kim MJ; Jeong HR; Bae IH; Ahn YG; Suh KH; Cho IJ; Kang JS; Hong YS; Lee JS; Jin DH; Kim TW
Invest New Drugs; 2020 Dec; 38(6):1696-1706. PubMed ID: 32462369
[TBL] [Abstract][Full Text] [Related]
52. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
[TBL] [Abstract][Full Text] [Related]
53. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
54. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.
Bertrand MJ; Milutinovic S; Dickson KM; Ho WC; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Barker PA
Mol Cell; 2008 Jun; 30(6):689-700. PubMed ID: 18570872
[TBL] [Abstract][Full Text] [Related]
55. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
[TBL] [Abstract][Full Text] [Related]
56. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
Jiménez-Lara AM; Aranda A; Gronemeyer H
Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
[TBL] [Abstract][Full Text] [Related]
57. Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.
Hashimoto K; Saito B; Miyamoto N; Oguro Y; Tomita D; Shiokawa Z; Asano M; Kakei H; Taya N; Kawasaki M; Sumi H; Yabuki M; Iwai K; Yoshida S; Yoshimatsu M; Aoyama K; Kosugi Y; Kojima T; Morishita N; Dougan DR; Snell GP; Imamura S; Ishikawa T
J Med Chem; 2013 Feb; 56(3):1228-46. PubMed ID: 23298277
[TBL] [Abstract][Full Text] [Related]
58. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.
Sun H; Liu L; Lu J; Bai L; Li X; Nikolovska-Coleska Z; McEachern D; Yang CY; Qiu S; Yi H; Sun D; Wang S
J Med Chem; 2011 May; 54(9):3306-18. PubMed ID: 21462933
[TBL] [Abstract][Full Text] [Related]
59. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
Lu J; McEachern D; Sun H; Bai L; Peng Y; Qiu S; Miller R; Liao J; Yi H; Liu M; Bellail A; Hao C; Sun SY; Ting AT; Wang S
Mol Cancer Ther; 2011 May; 10(5):902-14. PubMed ID: 21372226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
